(NASDAQ: MOLN) Molecular Partners Ag's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.6%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 15.33%.
Molecular Partners Ag's earnings in 2025 is -$72,547,560.On average, 3 Wall Street analysts forecast MOLN's earnings for 2025 to be -$70,161,529, with the lowest MOLN earnings forecast at -$77,781,130, and the highest MOLN earnings forecast at -$60,455,476. On average, 3 Wall Street analysts forecast MOLN's earnings for 2026 to be -$61,071,089, with the lowest MOLN earnings forecast at -$90,314,583, and the highest MOLN earnings forecast at -$39,074,881.
In 2027, MOLN is forecast to generate $46,816,131 in earnings, with the lowest earnings forecast at $46,816,131 and the highest earnings forecast at $46,816,131.